Access to dietary treatment
OtherDietary treatment using current nutrition guidelines, dialogic communication and Nutrition Care Process repeatedly by weekly access to a dietitian for four month.
NCT Number: NCT06996405
Objective:
The aim of this study is to explore the effect of access to individual dietary counselling by a dietitian in the dialysis unit on biochemical values (phosphorus and potassium), diet, nutritional status, quality of life (QoL) and health literacy (HL).
Hypothesis: Having access to a dietitian can better laboratory values and affect dietary intake, nutritional status, QoL and HL in a positive matter.
Method:
Pilot cluster RCT study in three the dialysis units in Region Zealand. Clustering of people on dialysis the same day to either intervention or control group. The groups is expected to be similar regarding clinical characteristics.
Primary outcome: Change in average p-phosphate Secondary outcomes: Change in average p-potassium, number of phosphate binders, number of potassium binders, HeartDiet-score, Nutritional Status, Adherence to diet (End Stage Renal Disease Adherence Questionnaire), Quality of life (Kidney Disease Quality of Life Short Form) and Health literacy (Health Literacy Questionnaire)
Intervention:
The intervention group receives an initial individual dietary interview, monthly follow-up and weekly access to a dietitian in the dialysis unit for four months. The control group receives usual care with referral to a dietitian when needed.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
Holbæk Dialysis Unit, Holbæk, Denmark
Objective:
The aim of this study is to explore the effect of access to individual dietary counselling by a dietitian in the dialysis unit on biochemical values (phosphorus and potassium), diet, nutritional status, quality of life (QoL) and health literacy (HL).
Research question:
What is the effect of access to dietary treatment in people receiving dialysis treatment on biochemical values (phosphorus and potassium), diet, nutritional status, quality of life and health literacy? Hypothesis: Having access to a dietitian can better laboratory values and affect dietary intake, nutritional status, QoL and HL in a positive matter.
Method:
Pilot cluster RCT study in the dialysis units in Holbæk and Slagelse in Region Zealand, Denmark. Clustering of people on dialysis the same day to either intervention or control group. The groups is expected to be similar regarding clinical characteristics. A pilot project will be conducted in 2024 in the dialysis units in Slagelse and Holbæk.
Data collection:
Both groups:
Primary outcome: Change in average p-phosphate Secondary outcomes: Change in average p-potassium, number of phosphate binders, number of potassium binders, HeartDiet-score, Nutritional Status (nutritional screening), Adherence to diet (End Stage Renal Disease Adherence Questionnaire, ESRD-AQ-score), Quality of life (Kidney Disease Quality of Life Short Form, KDQOL-SF-score) and Health literacy (Health Literacy Questionnaire, HLQ-score)
Intervention:
The intervention group receives an initial individual dietary interview, monthly follow-up and weekly access to a dietitian in the dialysis unit for four months.
The individualized dietary treatment based on the patient's preferences and needs according to the Nutrition Care Process. It is carried out according to the practical guidelines from the Danish Dietetic Association on dietary treatment of chronic kidney disease. The dietary treatment uses a dialogic and person-centered approach The intervention is described in the protocol using the TIDieR framework. The control group receives usual care with referral to a dietitian when needed.
Statistics:
The average phosphorus level and standard deviation after a diet intervention was 1.58 ± 0.32 mmol/l, therefore using 0.32 mmol/l in calculation of sample size. An implementation of guidelines and a systematic review showed a difference in phosphosus levels between intervention and control group of 0.23 and 0.30 mmol/l respectively.
Calculation of sample size using "Sample Size Calculator (clincalc.com)". Using the values mentioned above, a power of 80% and a significance of 5% shows a sample size of 18-30 people in each group to show a significant change in phosphorus levels.
Comparison of changes in average values using unpaired t-test, including endpoints of p-phosphorous and p-potassium, QoL-score and health literacy score. For dichotomous endpoints such as nutritional score, comparison of the percentage of the groups within and without specific limits. Data analysis with intention-to-treat and statistical calculations by a person not familiar with the groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dietary treatment using current nutrition guidelines, dialogic communication and Nutrition Care Process repeatedly by weekly access to a dietitian for four month.
Time frame: At baseline and after 5 month at the end of the intervention period (last phosphate value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)
Difference in average phosphate-level between groups
Time frame: At baseline and after 5 month at the end of the intervention period (last phosphate value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)
Number of patients with phosphate-level within range
Time frame: At baseline and after 5 month at the end of the intervention period (last phosphate value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)
Number of patients experiencing a increase or decrease in phosphate to/ from range
Time frame: At baseline, changes within the intervention period, after 5 month at the end of the intervention period, and 6 and 12 month after the last day of the intervention
Change in numbers of prescribed phosphate binders
Time frame: At baseline and after 5 month at the end of the intervention period (last potassium value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)
Difference in average potassium-level between groups
Time frame: At baseline and after 5 month at the end of the intervention period (last potassium value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)
Number of patients with potassium-level within range
Time frame: At baseline and after 5 month at the end of the intervention period (last potassium value before termination of intervention), and 6 and 12 month post-intervention (counting from last day of intervention)
Number of patients experiencing a increase or decrease in potassium to/ from range
Time frame: At baseline, changes within the intervention period, after 5 month at the end of the intervention period, and 6 and 12 month after the last day of the intervention
Change in numbers of prescribed potassium binders
Time frame: At baseline and after 5 month at the end of the intervention period
Nutritional screening according to Nutritional Risk Screening (NRS-2002)
Time frame: At baseline and after 5 month at the end of the intervention period
Nutritional intake collected using the food frequency questionnaire HeartDiet
Time frame: At baseline and after 5 month at the end of the intervention period
Quality of Life-score using the questionnaire Kidney Disease Quality of Life Short Form (KDQOL-SF)
Time frame: At baseline and after 5 month at the end of the intervention period
Adherence-score using the questionnaire End Stage Renal Disease Adherence Questionnaire (ESRD-AQ)
Time frame: At baseline and after 5 month at the end of the intervention period
Symptom-score using the questionnaire The Integrated Palliative Outcome Scale - Renal (IPOS-RENAL)
Time frame: At baseline and after 5 month at the end of the intervention period
Health Literacy Questionnaire-score using the questionnaire Health Literacy Questionnaire (HLQ)
Zealand University Hospital
Other
EFFECT Diet - Cluster RCT and Qualitative Inquiry
Acronym: EFFECTdiet
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07237997
Dialysis, Dialysis Patients
Nottingham, United Kingdom
View Trial DetailsNCT06838819
Chronic Disease, Continuous Glucose Monitoring
Hong Kong
View Trial DetailsNCT04776811
Chronic Disease, Diabetes Mellitus
Hong Kong, None Selected, China
View Trial DetailsNCT05793138
Chronic Disease, Chronic Kidney Diseases
Durham, North Carolina, United States
View Trial Details